A detailed history of Resona Asset Management Co.,Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 248,756 shares of LLY stock, worth $217 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
248,756
Holding current value
$217 Million
% of portfolio
1.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $181 Million - $232 Million
248,756 New
248,756 $192 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $829B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Resona Asset Management Co.,Ltd. Portfolio

Follow Resona Asset Management Co.,Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resona Asset Management Co.,Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Resona Asset Management Co.,Ltd. with notifications on news.